ALGERT GLOBAL LLC - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 50 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 5.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALGERT GLOBAL LLC ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$72,000
+35.8%
14,949
-24.3%
0.01%
-44.4%
Q2 2021$53,000
-59.8%
19,737
-53.9%
0.02%
-57.1%
Q1 2021$132,000
+140.0%
42,857
+177.1%
0.04%
+162.5%
Q4 2020$55,000
+22.2%
15,467
+37.5%
0.02%
+14.3%
Q3 2020$45,000
+25.0%
11,247
-33.6%
0.01%
-6.7%
Q1 2020$36,00016,9470.02%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$11,661,0002.42%
Telemetry Investments, L.L.C. 189,081$673,0001.14%
CHI Advisors LLC 490,877$1,748,0000.49%
BVF INC/IL 1,943,712$6,920,0000.27%
Orbimed Advisors 6,767,584$24,093,0000.21%
Novo Holdings A/S 847,906$3,019,0000.13%
Golden Green, Inc. 19,539$70,0000.06%
ALGERT GLOBAL LLC 15,467$55,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 133,700$476,0000.01%
Hikari Power Ltd 19,959$71,0000.01%
View complete list of CORVUS PHARMACEUTICALS INC shareholders